Issue 2/2022
Content (29 Articles)
Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy
Manoj Kumar, Zaigham Abbas, Milad Azami, Maria Belopolskaya, A. K. Dokmeci, Hasmik Ghazinyan, Jidong Jia, Ankur Jindal, Han Chu Lee, Wei Lei, Seng Gee Lim, Chun-Jen Liu, Qiang Li, Mamun Al Mahtab, David H. Muljono, Madunil Anuk Niriella, Masao Omata, Diana A. Payawal, Shiv K. Sarin, Olivier Ségéral, Tawesak Tanwandee, Nirupma Trehanpati, Kumar Visvanathan, Jin Mo Yang, Man‑Fung Yuen, Yingjie Zheng, Y. H. Zhou
Is lean non-alcoholic fatty liver disease a distinct entity?
Huapeng Lin, Vincent Wai-Sun Wong
Management of hepatitis B virus reactivation due to treatment of COVID-19
Terry Cheuk-Fung Yip, Madeleine Gill, Grace Lai-Hung Wong, Ken Liu
Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: a meta-analysis
Jie Ning Yong, Cheng Han Ng, Chloe Wen-Min Lee, Yu Yi Chan, Ansel Shao Pin Tang, Margaret Teng, Darren Jun Hao Tan, Wen Hui Lim, Jingxuan Quek, Jieling Xiao, Yip Han Chin, Roger Foo, Mark Chan, Weiqin Lin, Mazen Noureddin, Mohammad Shadab Siddiqui, Mark D. Muthiah, Arun Sanyal, Nicholas W. S. Chew
Sequential HBV treatment with tenofovir alafenamide for patients with chronic hepatitis B: week 96 results from a real-world, multicenter cohort study
Eiichi Ogawa, Makoto Nakamuta, Toshimasa Koyanagi, Aritsune Ooho, Norihiro Furusyo, Eiji Kajiwara, Kazufumi Dohmen, Akira Kawano, Takeaki Satoh, Kazuhiro Takahashi, Koichi Azuma, Nobuyuki Yamashita, Naoki Yamashita, Rie Sugimoto, Hiromasa Amagase, Masami Kuniyoshi, Yasunori Ichiki, Chie Morita, Masaki Kato, Shinji Shimoda, Hideyuki Nomura, Jun Hayashi
Cost-effectiveness of antiviral therapy in untreated compensated cirrhosis patient with serum HBV–DNA level < 2000 IU/mL
Hankil Lee, Sungin Jang, Sang Hoon Ahn, Beom Kyung Kim
CRISPR/Cas13-assisted hepatitis B virus covalently closed circular DNA detection
Xiangying Zhang, Yuan Tian, Ling Xu, Zihao Fan, Yaling Cao, Yingmin Ma, Hao Li, Feng Ren
MRE-based NASH score for diagnosis of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease
Young-Sun Lee, Ji Eun Lee, Hyon-Seung Yi, Young Kul Jung, Dae Won Jun, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Baek-hui Kim, Jeong Woo Kim, Chang Hee Lee, Jong Eun Yeon, Juneyoung Lee, Soon Ho Um, Kwan Soo Byun
Distinctive clinical and genetic features of lean vs overweight fatty liver disease using the UK Biobank
Daljeet Chahal, Divya Sharma, Sareh Keshavarzi, Fakhar Ali Qazi Arisar, Keyur Patel, Wei Xu, Mamatha Bhat
Gender differences in the association of body composition and biopsy-proved nonalcoholic steatohepatitis
Da Fang, Wenjuan Tang, Xiaoyu Zhao, Haixiang Sun, Tianwei Gu, Yan Bi
Carbohydrate-deficient transferrin is a sensitive marker of alcohol consumption in fatty liver disease
Maki Morinaga, Kazuyoshi Kon, Akira Uchiyama, Hiroo Fukada, Kyoko Fukuhara, Reiko Yaginuma, Eisuke Nakadera, Shunhei Yamashina, Kenichi Ikejima
Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
Phillipp Hartmann, Yi Duan, Yukiko Miyamoto, Münevver Demir, Sonja Lang, Elda Hasa, Patrick Stern, Dennis Yamashita, Mary Conrad, Lars Eckmann, Bernd Schnabl
Magnetic resonance elastography and proton density fat fraction predict adverse outcomes in hepatocellular carcinoma
Rex Wan-Hin Hui, Albert Chi-Yan Chan, Gladys Lo, Regina Lo, Cura Chan, Clarence Nicholas Kotewall, Lung-Yi Mak, Wong-Hoi She, Kin-Pan Au, Victor Ai, James Fung, Man-Fung Yuen, Wai-Kay Seto
Image-matching digital macro-slide—a novel pathological examination method for microvascular invasion detection in hepatocellular carcinoma
Hong-Ming Yu, Kang Wang, Jin-Kai Feng, Lei Lu, Yu-Chen Qin, Yu-Qiang Cheng, Wei-Xing Guo, Jie Shi, Wen-Ming Cong, Wan Yee Lau, Hui Dong, Shu-Qun Cheng
Abnormal bile acid-microbiota crosstalk promotes the development of hepatocellular carcinoma
Rui Shen, Lixin Ke, Qiao Li, Xi Dang, Shunli Shen, Jianming Shen, Shaoqiang Li, Lijian Liang, Baogang Peng, Ming Kuang, Yi Ma, Zhonghan Yang, Yunpeng Hua
Serum TERT C228T is an important predictor of non-viral liver cancer with fatty liver disease
Norio Akuta, Yusuke Kawamura, Fumitaka Suzuki, Mariko Kobayashi, Yasuji Arase, Satoshi Saitoh, Nozomu Muraishi, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Yoshiyuki Suzuki, Kenji Ikeda, Hiromitsu Kumada
A novel machine learning-based radiomic model for diagnosing high bleeding risk esophageal varices in cirrhotic patients
Yijie Yan, Yue Li, Chunlei Fan, Yuening Zhang, Shibin Zhang, Zhi Wang, Tehui Huang, Zhenjia Ding, Keqin Hu, Lei Li, Huiguo Ding
Fecal microbiota transplantation in alcohol-associated acute-on-chronic liver failure: an open-label clinical trial
Anima Sharma, Akash Roy, Madhumita Premkumar, Nipun Verma, Ajay Duseja, Sunil Taneja, Sandeep Grover, Madhu Chopra, Radha K. Dhiman
Alterations of gut microbiome and metabolite profiles in choledocholithiasis concurrent with cholangitis
Zhiyuan Hao, Kegong Tao, Kaiming Wu, Yuanyuan Luo, Yiting Lu, Binbin Li, Peimei Shi, Peiqin Wang, Xin Zeng, Yong Lin
Hepatic tuberculosis masquerading as malignancy
Aditya Kale, Prachi S. Patil, Utkarsh Chhanchure, Kedar Deodhar, Suyash Kulkarni, Shaesta Mehta, Sandeep Tandon
‘Hepatic tuberculosis: a sheep in wolf’s clothing’. Author response
Aditya Kale, Prachi S. Patil, Suyash Kulkarni, Sandeep Tandon, Kedar Deodhar
Drug-induced liver injury from herbal and dietary supplements: a problem in the East and West alike
Emily Nash, John Chetwood, Simone I. Strasser, Ken Liu
Histology activity index: a benchmark for decision making
Shaheena Parveen, Avinash Tiwari, Aadil Ashraf
Immune checkpoint inhibitors in chronic hepatitis B: therapy or high-risk factor for reactivation?
Chao Cai, Hui-Fang Zhang, Nai-Bin Yang, Ming-Qin Lu
Are immune-checkpoint inhibitors immunosuppressive to hepatitis B virus?
George Lau, Ming-Lung Yu, Grace Wong, Alexander Thompson
Correction to: Consensus on the secondary prevention of primary liver cancer
Yuemin Nan, Xiaoyuan Xu, Yanhang Gao, Rongqi Wang, Wengang Li, Ming Yang, Lingdi Liu, Zhongping Duan, Jidong Jia, Lai Wei, Hui Zhuang, Huiguo Ding, Zhongping Duan, Jiangao Fan, Qinmao Fang, Yanhang Gao, Peng Hu, Jidong Jia, Wengang Li, Jingfeng Liu, Junqi Niu, Yuemin Nan, Jia Shang, Rongqi Wang, Lai Wei, Yanyan Yu, Yuguo Zhang, Suxian Zhao, Jian Zhou, Weifeng Zhao, Xiaoyuan Xu, Chuanmiao Xie, Wen Xie, Ming Yang, Hui Zhuang
Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy
George Lau, Ming-Lung Yu, Grace Wong, Alexander Thompson, Hasmik Ghazinian, Jin-Lin Hou, Teerha Piratvisuth, Ji-Dong Jia, Masashi Mizokami, Gregory Cheng, Guo-Feng Chen, Zhen-Wen Liu, Oidov Baatarkhuu, Ann Lii Cheng, Woon Leung Ng, Patrick Lau, Tony Mok, Jer-Ming Chang, Saeed Hamid, A. Kadir Dokmeci, Rino A. Gani, Diana A. Payawal, Pierce Chow, Joong-Won Park, Simone I. Strasser, Rosmawaiti Mohamed, Khin Maung Win, Tawesak Tanwandee, Shiv Kumar Sarin, Masao Omata
Correction to: The association between metabolic risk factors, nonalcoholic fatty liver disease, and the incidence of liver cancer: a nationwide population-based cohort study
Yu-Guang Chen, Chih-Wei Yang, Chi-Hsiang Chung, Ching-Liang Ho, Wei-Liang Chen, Wu-Chien Chien